Skip to main content

Advertisement

Table 1 Baseline characteristics of the 50 patients

From: High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial

  ALL N = 50
Age (years), median (IQR) 71.50 (56.75; 79.25)
Gender, male n (%) 30 (60.0)
Dialysis vintage (months), median (IQR) 47.0 (26.5; 110.5)
Diabetes, n (%) 18 (36.0)
Hypertension, n (%) 38 (76.0)
Smoking, n (%) 8 (16.0)
Calcification score, median (IQR) 7.0 (2.0; 13.25)
Baseline dp-ucMGP (pM), median (IQR) 3179.15 (1825.25; 4339.50)
NCBB, n (%) 20 (40.0)
Residual diuresis, n (%) 6 (12.0)
Calcium dose (tablets of 600 mg), median (IQR) 1.00 (1.00; 2.25)
Alfacalcidol dose (μg), median (IQR) 0.75 (0.00; 1.50)
Serum phosphate (mg/dl), median (IQR) 3.90 (3.17; 4.65)
Serum calcium (mg/dl), median (IQR) 9.10 (8.80; 9.30)
PTH (pg/ml), median (IQR) 188.50 (117.75; 266.50)
LDL cholesterol (mg/dl), median (IQR) 92.0 (77.0; 113.0)
BMI (Kg/m2), median (IQR) 25.82 (22.85; 28.42)
URR, median (IQR) 75.0 (71.0; 79.0)
Albumin (g/l), median (IQR) 39.0 (36.0; 41.0)
CAD, n (%) 14 (28.0)
Cinacalcet, n (%) 2 (4.0)
Previous acenocoumadin, n (%) 6 (12.0)
PTHX, n (%) 2 (4.0)
Recent fracture, n (%) 3 (6.0)
  1. Abbreviations: NCBB non-calcium-based phosphate binders, PTH intact parathyroid hormone, BMI body mass index, URR urea reduction ratio, CAD documented coronary artery disease, PTHX previous parathyroidectomy